Bhatheja Rohit, Mukherjee Debabrata
Gill Heart Institute, Division of Cardiovascular Medicine, University of Kentucky, Lexington, KY 40536-0200, USA.
Crit Care Clin. 2007 Oct;23(4):709-35, v. doi: 10.1016/j.ccc.2007.07.003.
Acute coronary syndrome is a major health problem affecting approximately 1.5 million individuals a year. Early diagnosis and appropriate evidence-based therapies improve clinical outcomes significantly. Current data suggest that an early invasive therapy may improve intermediate-term and long-term outcomes, particularly in high-risk individuals. The last few years also have seen significant advances in antiplatelet and antithrombotic therapies for the management of patients who have acute coronary syndrome.
急性冠状动脉综合征是一个重大的健康问题,每年影响约150万人。早期诊断和适当的循证治疗可显著改善临床结局。目前的数据表明,早期侵入性治疗可能改善中期和长期结局,尤其是在高危个体中。在过去几年中,用于治疗急性冠状动脉综合征患者的抗血小板和抗血栓治疗也取得了重大进展。